Sign in

CIK 0001867066 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Journey Medical Corp

Sign in to watch
Ticker
DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471879539
Phone
480-434-6670
Business address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
  1. 4 Grant or award Director acquired 9,728 shares (grant or award)
  2. 4 Grant or award Director acquired 9,728 shares (grant or award)
  3. 4 Grant or award Director acquired 9,728 shares (grant or award)
  4. 4 Other disposition 10% owner disposed of 250,000 shares (other)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 10,000 shares at $3.04 ($30,400)
  7. 4 Open-market buy President & CEO bought 10,000 shares at $3.48 ($34,790)
  8. 4 Open-market buy Director bought 30,000 shares at $3.47 ($104,100)
  9. 4 Open-market buy Director bought 20,000 shares at $3.40 ($68,000)
  10. 4 Open-market sale Interim CFO sold 2,450 shares at $3.75 ($9,188)
  11. 4 Open-market sale Director sold 2,500 shares at an average $3.51 ($8,771)
  12. 4 Open-market sale Director sold 1,745 shares at $5.22 ($9,109)
  13. 4 Open-market buy Director bought 33,000 shares at $2.98 ($98,340)
  14. 4 Open-market buy Director bought 15,000 shares at $2.98 ($44,700)
  15. 4 Open-market buy Director bought 30,000 shares at $2.97 ($89,100)
  16. 4 Open-market buy President & CEO bought 26,044 shares at $2.52 ($65,631)
  17. 4 Open-market buy Director bought 100,000 shares at $2.23 ($223,000)
  18. 4 Grant or award Director acquired 27,472 shares (grant or award)
  19. 4 Grant or award Director acquired 27,472 shares (grant or award)
  20. 4 Grant or award Director acquired 27,472 shares (grant or award)

Page 3 of 5 · 88 filings